MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Argentine Translation and Adaptation of the Scale for the Assessment and Classification of Ataxia (SARA)

    J. Fernández Boccazzi, N. Gonzalez Rojas, M. Cesarini, G. da Prat, J. Etcheverry, E. Gatto (Buenos Aires, Argentina)

    Objective: Translate and cross-culturally adapt this instrument into Spanish and to carry out a pilot test for its subsequent validation in this language. Background: Ataxias…
  • 2023 International Congress

    A novel motor-learning based dysphagia treatment approach in Parkinson’s disease

    E. Wang, L. Verhagen Metman (Chicago, USA)

    Objective: This pilot study tested the effectiveness of a novel motor learning and exercise principle-based dysphagia treatment approach in PD. Background: Dysphagia occurs in 90% percent…
  • 2023 International Congress

    Angiotensin-converting enzyme inhibitors prevent pneumonia in patients with Parkinson’s disease

    A. Kim, JY. Joon Yeon (Cheongju-si, Republic of Korea)

    Objective: This study aimed to evaluate the effects of angiotensin-converting enzyme inhibitors (ACEi) on the prevalence of pneumonia in patients with Parkinson’s disease (PD). Background:…
  • 2023 International Congress

    Hazard ratios of suicidality in a large Huntington disease population compared with controls: marginal structural modeling of Enroll-HD registry data

    S. Reshef, V. Sung, G. Smith, O. Harari, D. Zhang, M. Forrest Gordon, R. Willock, R. Ribalov, J. Robles-Zurita, E. Furr Stimming (Parsippany-Troy Hills, USA)

    Objective: The aim of this study was to describe the risk of suicidality among individuals with versus those without Huntington disease (HD) from Enroll-HD. Background:…
  • 2023 International Congress

    Genetics of Neurogenic Orthostatic Hypotension in Parkinson’s Disease

    G. Chevalier, L. Udovin, M. Otero-Losada, S. Bordet, F. Capani, S. Luo, C. Goetz, S. Perez-Lloret (Buenos Aires, Argentina)

    Objective: We examined the association between NOH and PD-related Single Nucleotide Polymorphism (SNPs) and mapped their effects on gene expression and metabolic and signaling pathways.…
  • 2023 International Congress

    Cervical Dystonia as a post Wernicke’s Encephalopathy sequelae.

    V. Khardenavis, A. Deshpande (Madurai, India)

    Objective: To highlight the rare clinical presentation of cervical dystonia(sagittal shift) as a post Wernicke’s Encephalopathy sequelae. Background: Wernicke’s encephalopathy (WE) is a neurological emergency…
  • 2023 International Congress

    Prospective, Multicenter, International Registry of Deep Brain Stimulation for Dystonia: A Sub-Analysis of Cervical Dystonia Patients

    A. Albanese, S. Delvaux, L. Chen, R. Jain, J. Krauss (Milan, Italy)

    Objective: The objective of this study is to assess and report real-world outcomes of Dystonia patients implanted with Multiple Independent Current Control (MICC)-based directional Deep…
  • 2023 International Congress

    Leveraging MRI and machine-learning for early detection of cognitive impairment in Parkinson’s disease

    L. Saadatpour, A. Vijayakumari, B. Walter, H. Fernandez (Cleveland, USA)

    Objective: To develop a machine learning model using MRI data that predicts the likelihood of cognitive impairment in newly diagnosed patients with Parkinson's disease (PD).…
  • 2023 International Congress

    Comparative study of Non-Motor Symptoms and it’s correlation with Quality of Life in Parkinson’s disease and Atypical Parkinsonism

    D. Joshi, A. Kumar, M. Tapadia (varanasi, India)

    Objective: The present study aimed to evaluate and compare the non-motor symptoms and their correlation with quality of life in patients with PD and AP.…
  • 2023 International Congress

    Real-world utility of MANAGE PD tool by physicians and patients in Germany

    M. Südmeyer, D. Pedrosa, F. Siebecker, C. Arlt, J. Kopra, W. Jost (Potsdam, Germany)

    Objective: To investigate the utility of the MANAGE PD tool in routine clinical care in Germany and the planned next steps after the tool recommendation.…
  • « Previous Page
  • 1
  • …
  • 34
  • 35
  • 36
  • 37
  • 38
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley